GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Institutional Ownership

ReproCELLorp (TSE:4978) Institutional Ownership : 0.70% (As of May. 19, 2024)


View and export this data going back to 2013. Start your Free Trial

What is ReproCELLorp Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ReproCELLorp's institutional ownership is 0.70%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ReproCELLorp's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ReproCELLorp's Float Percentage Of Total Shares Outstanding is 0.00%.


ReproCELLorp Institutional Ownership Historical Data

The historical data trend for ReproCELLorp's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReproCELLorp Institutional Ownership Chart

ReproCELLorp Historical Data

The historical data trend for ReproCELLorp can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.64 0.65 0.65 0.66 0.66 0.67 0.67 0.69 0.70 0.70

ReproCELLorp Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


ReproCELLorp (TSE:4978) Business Description

Traded in Other Exchanges
N/A
Address
KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.

ReproCELLorp (TSE:4978) Headlines

No Headlines